< Back to all news

Recent publication: CONCOR-1 clinical trial

Sep 17, 2021 – The results of the randomized controlled trial CONCOR-1 (Convalescent Plasma for COVID-19 Respiratory Illness) have been published in Nature Medicine: https://www.nature.com/articles/s41591-021-01488-2

In summary: Convalescent plasma did not reduce the risk of intubation or death in hospitalized patients with COVID-19. However, the study also revealed that the antibody profile in the blood of people who have had the virus is extremely variable and this may modify the response to the treatment.

The clinical research team and several of our researchers including Dr. Alexis Turgeon were involved in this clinical trial.